Vor Biopharma (VOR) Shares Issued (2020 - 2026)
Vor Biopharma (VOR) reported Shares Issued of $75.0 million for Q1 2026, down 42.19% on a QoQ basis from $129.7 million in Q4 2025.
Vor Biopharma (VOR) has 7 years of Shares Issued data on file, last reported at $75.0 million in Q1 2026.
- Quarterly Shares Issued changed N/A year-over-year to $75.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $399.4 million (up 622.6% YoY) and the FY2025 annual result came in at $150.0 million, up 170.03% from the prior year.
- Shares Issued declined to $75.0 million in Q1 2026 per VOR's latest filing, from $129.7 million in the prior quarter.
- Across five years, Shares Issued topped out at $174.4 million in Q2 2025 and bottomed at -$278000.0 in Q2 2024.
- The 5-year median for Shares Issued is $348000.0 (2022), against an average of $29.0 million.
- The widest annual swing landed in 2023, when Shares Issued sank 114.15%; it then surged 368453.33% in 2024.
- Tracing VOR's Shares Issued over 5 years: stood at $106000.0 in 2022, then sank by 114.15% to -$15000.0 in 2023, then surged by 368453.33% to $55.3 million in 2024, then soared by 134.81% to $129.7 million in 2025, then slumped by 42.19% to $75.0 million in 2026.
- Per Business Quant, the three latest VOR Shares Issued figures stand at $75.0 million (Q1 2026), $129.7 million (Q4 2025), and $20.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Vor Biopharma | 628.83 Mn | 628.83 Mn | - | 75.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.00 Mn |
| Mar 31, 2026 | 75.00 Mn |
| Dec 31, 2025 | 129.74 Mn |
| Dec 31, 2025 | 129.74 Mn |
| Sep 30, 2025 | 20.26 Mn |
| Sep 30, 2025 | 20.26 Mn |
| Jun 30, 2025 | 174.40 Mn |
| Jun 30, 2025 | 174.40 Mn |
| Dec 31, 2024 | 55.25 Mn |
| Dec 31, 2024 | 55.25 Mn |
| Sep 30, 2024 | 297,000.00 |
| Sep 30, 2024 | 297,000.00 |
| Jun 30, 2024 | -278,000.00 |
| Jun 30, 2024 | -278,000.00 |
| Mar 31, 2024 | 278,000.00 |
| Mar 31, 2024 | 278,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Sep 30, 2023 | 392,000.00 |
| Sep 30, 2023 | 392,000.00 |
| Jun 30, 2023 | 4.19 Mn |
| Jun 30, 2023 | 4.19 Mn |
| Mar 31, 2023 | 14,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Dec 31, 2022 | 106,000.00 |
| Dec 31, 2022 | 106,000.00 |
| Sep 30, 2022 | 3.84 Mn |
| Sep 30, 2022 | 3.84 Mn |
| Jun 30, 2022 | 304,000.00 |
| Jun 30, 2022 | 304,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Mar 31, 2021 | 189.20 Mn |
| Mar 31, 2021 | 189.20 Mn |
| Dec 31, 2020 | 46,000.00 |
| Dec 31, 2020 | 46,000.00 |
| Sep 30, 2020 | 153,000.00 |
| Sep 30, 2020 | 153,000.00 |
| Jun 30, 2020 | 17,000.00 |
| Jun 30, 2020 | 17,000.00 |
| Mar 31, 2020 | 43,000.00 |
| Mar 31, 2020 | 43,000.00 |